Product Profile of Asparaginase Based Injection For Leukemia
Asparaginase based Injection for Leukemia comes in the packing of 5 Vials of 10,000 KU/Vial. The Asparaginase based Injection is used to treat acute lymphoblastic leukemia, acute myeloid leukemia and malignant lymphoma. The Asparaginase based Injection should be taken in the dosage range of 50 to 200 KU/kg bodyweight daily or every alternate day, given intravenously or intramuscularly. The Asparaginase based Injection for Leukemia must be tested before starting treatment.
Key Features of Asparaginase Based Injection For Leukemia
- Used to treat acute lymphoblastic leukemia, acute myeloid leukemia and malignant lymphoma
- Should be taken in the dosage range of 50 to 200 KU/kg bodyweight daily or every alternate day, given intravenously or intramuscularly
- Must be tested before starting treatment
- Comes in the packing of 5 Vials of 10,000 KU/Vial
